BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37319242)

  • 1. Examination of two different proteasome inhibitors in reactivating mutant human cystathionine β-synthase in mice.
    Gupta S; Lee HO; Wang L; Kruger WD
    PLoS One; 2023; 18(6):e0286550. PubMed ID: 37319242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.
    Gupta S; Wang L; Anderl J; Slifker MJ; Kirk C; Kruger WD
    Hum Mutat; 2013 Aug; 34(8):1085-93. PubMed ID: 23592311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70.
    Singh LR; Gupta S; Honig NH; Kraus JP; Kruger WD
    PLoS Genet; 2010 Jan; 6(1):e1000807. PubMed ID: 20066033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine β-synthase (
    Gupta S; Kelow S; Wang L; Andrake MD; Dunbrack RL; Kruger WD
    J Biol Chem; 2018 Sep; 293(36):13921-13931. PubMed ID: 30030379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c.797 G>A (p.R266K) cystathionine β-synthase mutation causes homocystinuria by affecting protein stability.
    Gupta S; Wang L; Kruger WD
    Hum Mutat; 2017 Jul; 38(7):863-869. PubMed ID: 28488385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Qatari R336C cystathionine β-synthase protein in mice.
    Gupta S; Gallego-Villar L; Wang L; Lee HO; Nasrallah G; Al-Dewik N; Häberle J; Thöny B; Blom HJ; Ben-Omran T; Kruger WD
    J Inherit Metab Dis; 2019 Sep; 42(5):831-838. PubMed ID: 31240737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants.
    Collard R; Majtan T
    Mol Cell Biol; 2023; 43(12):664-674. PubMed ID: 38051092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions.
    Majtan T; Pey AL; Ereño-Orbea J; Martínez-Cruz LA; Kraus JP
    Curr Drug Targets; 2016; 17(13):1455-70. PubMed ID: 26931358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.
    Wang L; Chen X; Tang B; Hua X; Klein-Szanto A; Kruger WD
    Hum Mol Genet; 2005 Aug; 14(15):2201-8. PubMed ID: 15972722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two pathogenic mutations in cystathionine beta-synthase: different intracellular locations for wild-type and mutant proteins.
    Casique L; Kabil O; Banerjee R; Martinez JC; De Lucca M
    Gene; 2013 Nov; 531(1):117-24. PubMed ID: 23981774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term functional correction of cystathionine β-synthase deficiency in mice by adeno-associated viral gene therapy.
    Lee HO; Salami CO; Sondhi D; Kaminsky SM; Crystal RG; Kruger WD
    J Inherit Metab Dis; 2021 Nov; 44(6):1382-1392. PubMed ID: 34528713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria.
    Majtan T; Kožich V; Kruger WD
    Br J Pharmacol; 2023 Feb; 180(3):264-278. PubMed ID: 36417581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria.
    Majtan T; Pey AL; Gimenez-Mascarell P; Martínez-Cruz LA; Szabo C; Kožich V; Kraus JP
    Handb Exp Pharmacol; 2018; 245():345-383. PubMed ID: 29119254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Cystathionine β-Synthase Deficiency in Mice Using a Minicircle-Based Naked DNA Vector.
    Lee HO; Gallego-Villar L; Grisch-Chan HM; Häberle J; Thöny B; Kruger WD
    Hum Gene Ther; 2019 Sep; 30(9):1093-1100. PubMed ID: 31084364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to fix a broken protein: restoring function to mutant human cystathionine β-synthase.
    Kruger WD
    Hum Genet; 2022 Jul; 141(7):1299-1308. PubMed ID: 34636997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model.
    Bublil EM; Majtan T; Park I; Carrillo RS; Hůlková H; Krijt J; Kožich V; Kraus JP
    J Clin Invest; 2016 Jun; 126(6):2372-84. PubMed ID: 27183385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria.
    Majtan T; Hůlková H; Park I; Krijt J; Kožich V; Bublil EM; Kraus JP
    FASEB J; 2017 Dec; 31(12):5495-5506. PubMed ID: 28821635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.
    Gupta S; Wang L; Kruger WD
    J Inherit Metab Dis; 2016 Jan; 39(1):39-46. PubMed ID: 26231230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis.
    Shan X; Dunbrack RL; Christopher SA; Kruger WD
    Hum Mol Genet; 2001 Mar; 10(6):635-43. PubMed ID: 11230183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones.
    Kopecká J; Krijt J; Raková K; Kožich V
    J Inherit Metab Dis; 2011 Feb; 34(1):39-48. PubMed ID: 20490928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.